questionText: To ask the Secretary of State for Health and Social Care, if she will provide a timescale of when she expects (a) NHS England to conclude its commercial negotiations with Vertex Pharmaceuticals and (b) NICE to issue final guidance on NHS availability of K
answerText: Commercial negotiations between NHS England and Vertex remain on track and are being undertaken constructively, and within a confidential environment, to best enable progress. NHS England remains committed to ensuring patients, and the wider community of ...
heading: Ivacaftor/tezacaftor/elexacaftor: Vertex